In vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis (Q64103896)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

title

In vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

main subject

systemic mastocytosis

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Jean-Marie Launay

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Siham Bibi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Michel Arock

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Fawzia Louache

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

author name string

Yanyan Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Ghaith Wedeh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Liang He

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Florian Beghi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Viviane Baral

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Fernando Doñate

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

Hosein Kouros-Mehr

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

language of work or name

English

0 references

publication date

1 February 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

page(s)

633-643

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

Phenotypic characterization of the human mast-cell line HMC-1.

25 April 2020

cites work

1 reference

12 December 2020

The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors.

1 reference

12 December 2020

Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-3 (E-NPP3/CD203c/PD-I beta/B10/gp130RB13-6) in human colon carcinoma

1 reference

12 December 2020

Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-1 (E-NPP1/PC-1) and -3 (E-NPP3/CD203c/PD-Ibeta/B10/gp130(RB13-6)) in inflammatory and neoplastic bile duct diseases

1 reference

12 December 2020

CD203c /CD117-, an useful phenotype profile for acute basophilic leukaemia diagnosis in cases of undifferentiated blasts.

1 reference

12 December 2020

Recent advances in the understanding of mastocytosis: the role of KIT mutations.

1 reference

12 December 2020

CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking.

1 reference

12 December 2020

Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer

1 reference

12 December 2020

Smouldering systemic mastocytosis: a rare disorder with a difficult diagnosis

1 reference

12 December 2020

A water-soluble coelenterazine for sensitive in vivo imaging of coelenterate luciferases

1 reference

12 December 2020

CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.

1 reference

12 December 2020

Antibody-drug conjugates in cancer therapy

1 reference

12 December 2020

Drug-conjugated antibodies for the treatment of cancer

1 reference

12 December 2020

Antibody-drug conjugates: present and future

1 reference

12 December 2020

A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection

1 reference

12 December 2020

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

1 reference

12 December 2020

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

1 reference

12 December 2020

The ectoenzyme E-NPP3 negatively regulates ATP-dependent chronic allergic responses by basophils and mast cells.

1 reference

12 December 2020

Current treatment options in patients with mastocytosis: status in 2015 and future perspectives

1 reference

12 December 2020

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia

1 reference

12 December 2020

Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids

1 reference

12 December 2020

AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma

1 reference

12 December 2020

Regulation of allergic inflammation by the ectoenzyme E-NPP3 (CD203c) on basophils and mast cells

1 reference

12 December 2020

Antibody-drug conjugates for cancer therapy.

1 reference

12 December 2020

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

1 reference

12 December 2020

Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management

1 reference

12 December 2020

A new humanized in vivo model of KIT D816V advanced systemic mastocytosis monitored using a secreted luciferase.

1 reference

12 December 2020

Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.

1 reference

12 December 2020

Midostaurin: a magic bullet that blocks mast cell expansion and activation

1 reference

12 December 2020

10.1182/BLOODADVANCES.2018026179

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30804017 AND SRC:MED&resulttype=core&format=json

25 April 2020

PubMed publication ID

30804017

1 reference